NPPA and colorectal carcinoma: Overall, despite the well-known sparseness of peptides and phosphopeptides detected by proteomic assays, mVESPA quantitatively assessed the activity of 371 KP-enzymes—i.e., around half of all known human KP-enzymes and around 66.7% of the KP-enzymes estimated to be expressed in CRC cells (Methods).